Related Experiment Video
Updated: Jun 24, 2026

07:12
Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves
Published on: August 23, 2011
Endothelialization of heart valve matrix using a computer-assisted pulsatile bioreactor
Dong Joon Lee1, Julie Steen, James E Jordan
1Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina, USA.
Tissue Engineering. Part A
|March 27, 2009
Summary
Endothelial progenitor cell (EPC)-derived endothelial cells (ECs) improve bioprosthetic heart valve function. Preconditioning EC-seeded scaffolds in a bioreactor enhances anti-thrombotic properties, reducing clot formation risk post-implantation.
Area of Science:
- Biomaterials Science
- Cardiovascular Engineering
- Tissue Engineering
Background:
- Bioprosthetic heart valves are prone to calcification and tissue deterioration, leading to thromboembolism.
- Endothelialization of valve surfaces is a strategy to minimize thrombosis.
- Optimal conditions for endothelialization of decellularized heart valves require investigation.
Purpose of the Study:
- To define optimal flow parameters for endothelialization of decellularized heart valves using endothelial progenitor cell (EPC)-derived endothelial cells (ECs).
- To assess the thrombogenic characteristics of endothelialized heart valve surfaces using a bioreactor.
Main Methods:
- Decellularized porcine valve scaffolds were seeded with EPC-derived ECs.
- A computer-controlled bioreactor system was used to determine optimal flow rates.
- Successful endothelialization was achieved by preconditioning cell-seeded valves with stepwise increases in volume flow rate up to 2 L/min for 7 days.
Main Results:
- EC-seeded decellularized valve scaffolds demonstrated improved anti-thrombotic properties.
- Unseeded scaffolds showed an escalation of the coagulation process.
- Bioreactor preconditioning facilitated uniform endothelialization of valve scaffolds.
Conclusions:
- Bioreactor-mediated preconditioning is essential for uniform endothelialization of EC-seeded valve scaffolds.
- This approach may significantly reduce thrombotic activity after in vivo implantation of bioprosthetic heart valves.
- Optimized endothelialization enhances the safety and efficacy of bioprosthetic heart valves.
